Correlation Between Verrica Pharmaceuticals and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Enliven Therapeutics, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Enliven Therapeutics.
Diversification Opportunities for Verrica Pharmaceuticals and Enliven Therapeutics
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Verrica and Enliven is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Enliven Therapeutics
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to generate 2.33 times more return on investment than Enliven Therapeutics. However, Verrica Pharmaceuticals is 2.33 times more volatile than Enliven Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 68.00 in Verrica Pharmaceuticals on November 18, 2024 and sell it today you would earn a total of 6.00 from holding Verrica Pharmaceuticals or generate 8.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Enliven Therapeutics
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Enliven Therapeutics |
Verrica Pharmaceuticals and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Enliven Therapeutics
The main advantage of trading using opposite Verrica Pharmaceuticals and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |